TAP HOLDINGS INC has a total of 25 patent applications. Its first patent ever was published in 1994. It filed its patents most often in United States, Australia and Israel. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are TAP PHARMACEUTICAL PROD INC, OPKO IRELAND GLOBAL HOLDINGS LTD and N GENE RES LABORATORIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Australia | 4 | |
#3 | Israel | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Canada | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Brazil | 1 | |
#8 | China | 1 | |
#9 | Japan | 1 | |
#10 | Mexico | 1 | |
#11 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Gupta Pramod K | 12 |
#2 | Mansfield Robert K | 6 |
#3 | Bollinger John Daniel | 6 |
#4 | Davis Craig W | 5 |
#5 | Reiland Thomas L | 5 |
#6 | Chen Yisheng | 5 |
#7 | Zheng Jack Yuqun | 5 |
#8 | Sison Raymundo A | 5 |
#9 | Lee Dennis Y | 5 |
#10 | Bollinger John D | 5 |
Publication | Filing date | Title |
---|---|---|
AU3512902A | Treatment of anti-depression drug-induced sexual dysfunction with apomorphine | |
MXPA02006034A | Oral mucosal dosage forms of apomorphine. | |
US6291471B1 | Use of apomorphine for the treatment of organic erectile dysfunction in males | |
US6020380A | Method of treating chronic obstructive pulmonary disease | |
US5516759A | LHRH antagonists having lactam groups at the N-terminus | |
US5502035A | N-terminus modified analogs of LHRH | |
US5508383A | Cyclic peptide LHRH antagonists |